/PRNewswire/ Cipla USA, the subsidiary of multinational pharmaceutical company Cipla earns the coveted Great Place To Work® certification by the Great Place.
The Global Sympathomimetic Drugs Market reach USD 9.87 Billion in 2021 and is expected to exhibit a CAGR of 11.34% over the forecast period 2023 to 2032,